Novacyt trading update Paris, France and Camberley, UK – 24 December 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics products, on the 11 December announced its decision to sell the NOVAprep® business unit. As a result, the Company confirms that NOVAprep® will be treated as a discontinued operation under
Visit PageYear: 2018
Point sur l’activité
Novacyt Point sur l’activité Paris, France et Camberley, UK – le 24 décembre 2018 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, a annoncé le 11 décembre sa décision de céder la division NOVAprep®. Le Groupe confirme que cette division sera traitée comptablement en normes IFRS comme activité
Visit PageNovacyt launches two new CE-IVD Marked molecular diagnostic kits
Novacyt launches two new molecular CE Mark assays First of an expanding menu of tests for monitoring post-transplantation and immunosuppressed patients
Visit Page